TREA

97632833 - BIOLOGY42

Follow

Information

  • Trademark
  • 97632833
  • Serial Number
    97632833
  • Registration Number
    7470850
  • Filing Date
    October 14, 2022
    2 years ago
  • Registration Date
    August 13, 2024
    9 months ago
  • Transaction Date
    August 13, 2024
    9 months ago
  • Status Date
    August 13, 2024
    9 months ago
  • Published for Opposition Date
    May 28, 2024
    11 months ago
  • Location Date
    August 12, 2024
    9 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    SPILS, CAROL A
  • Attorney Docket Number
    216786-0001
    Attorney Name
    Louise Arnott
  • Owners
Information
Mark Drawing Code
4
Mark Identification
BIOLOGY42
Case File Statements
  • GS0091: Computers, computer hardware and computer peripheral devices; downloadable mobile applications using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer software platforms using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer software using artificial intelligence for automated machine learning in the field of drug design and development; downloadable computer programs using artificial intelligence for automated machine learning in the field of drug design and development; recorded computer programs using artificial intelligence for automated machine learning in the field of drug design and development; computer operating programs, recorded; data processing apparatus being data processors; Electronic card readers; data processing equipment, namely, scanners; Downloadable computer software using artificial intelligence for machine learning in the field of drug design and development; Downloadable data sets using artificial intelligence for automated machine learning in the field of drug design and development; Data sets using artificial intelligence for automated machine learning in the field of drug design and development recorded on computer media; downloadable and recorded computer software platforms using artificial intelligence for automated machine learning in the field of drug design and development; computer operating programs, recorded, for automated machine learning in the field of drug design and development; data processing apparatus, namely, data processors for automated machine learning in the field of drug design and development
  • GS0421: Drug discovery research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; product research and development in the field of biotechnology, molecular biology, pharmaceutics, oncology, immunology, biology and chemistry; Scientific and technological services, namely, scientific research and analysis in the field of pharmaceutical drugs and product research and design relating thereto; artificial intelligence driven robotics drug discovery scientific laboratory services; design and development of computer hardware and software; Software as a service (SAAS) services featuring software for use in database management n the field of drug design and development; software development in the framework of software publishing; updating of computer software; Platform as a service (PAAS) featuring computer software platforms for use in database management in the field of drug design and development; development of computer platforms; computer system design; rental of computer software for using artificial intelligence for automated machine learning in the field of drug design and development; creating and designing website-based indexes of information in the field of drug design and development for others using information technology services; computer programming; maintenance of computer software; research and development of new products for others; scientific and technological research relating to patent mapping; scientific research; platform as a service (PaaS) featuring computer software platforms for use in database management for using artificial intelligence for automated machine learning in the field of drug design and development; research in the field of artificial intelligence; conversion of data or documents from physical to electronic media; conversion of computer programs and data, other than physical conversion; electronic data storage; computer programming service for data processing; providing medical and scientific research information; Providing a web site that gives computer users the ability to upload and share video-based scientific protocols and other scientific-based videos; provision of scientific information in the fields of pharmaceutical research and development, drug discovery and medical and scientific research; computer software design; software as a service (SaaS) services featuring software for using artificial intelligence for automated machine learning in the field of drug design and development; platform as a service (PaaS) featuring computer software platforms for using artificial intelligence for automated machine learning in the field of drug design and development; creating and designing website based indexes of data and information for others using information technology; computer programming services; installation of computer software; installation, maintenance, and updating of computer software; installation of software using artificial intelligence for automated machine learning in the field of drug design and development; customizing computer software; custom design of computer software; developing customized software in the field of drug design and development
Case File Event Statements
  • 10/18/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/18/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/20/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/7/2023 - a year ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/7/2023 - a year ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/7/2023 - a year ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/13/2023 - a year ago
    7 - ASSIGNED TO LIE Type: ALIE
  • 6/13/2023 - a year ago
    8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/15/2023 - a year ago
    9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/25/2023 - a year ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/5/2023 - a year ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/25/2023 - a year ago
    12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/19/2023 - a year ago
    13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/13/2024 - a year ago
    14 - TEAS PETITION TO AMEND BASIS RECEIVED Type: TPAD
  • 3/19/2024 - a year ago
    17 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 4/2/2024 - a year ago
    15 - ASSIGNED TO PETITION STAFF Type: APET
  • 4/3/2024 - a year ago
    16 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG
  • 5/8/2024 - a year ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/28/2024 - 11 months ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/28/2024 - 11 months ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/13/2024 - 9 months ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/13/2024 - 9 months ago
    23 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 4/9/2024 - a year ago
    18 - CASE RETURNED TO EXAMINATION Type: OTHE